Aardvark Therapeutics Inc...

8.27
-0.25 (-2.93%)
At close: Apr 24, 2025, 3:59 PM
7.80
-5.68%
Pre-market: Apr 25, 2025, 05:18 AM EDT

Aardvark Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q4 2023 Q3 2023
Period Ending Dec 31, 2024 Sep 30, 2024 Dec 31, 2023 Sep 30, 2023
-17.11M -8.33M -4.15M -2.11M
17K 138K 51K 26K
459K 286K 141K 72K
-388K -10K -498K -260K
1.11M 930K 839K 742K
n/a n/a n/a n/a
1.1M 282K 378K -316K
-14.42M -6.7M -2.74M -1.58M
-11K -5K n/a n/a
n/a n/a n/a n/a
n/a n/a n/a n/a
n/a n/a n/a n/a
-11.89M n/a n/a n/a
-11.9M -5K n/a n/a
n/a n/a n/a n/a
n/a n/a n/a n/a
n/a n/a n/a n/a
-1.11M 64K n/a n/a
-950K 64K n/a n/a
-27.27M -6.64M -2.74M -1.58M
-14.43M -6.7M -2.74M -1.58M